Jens Bichel

921 total citations
12 papers, 661 citations indexed

About

Jens Bichel is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Jens Bichel has authored 12 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Jens Bichel's work include Nonmelanoma Skin Cancer Studies (7 papers), Diagnosis and Treatment of Venous Diseases (3 papers) and Cutaneous Melanoma Detection and Management (3 papers). Jens Bichel is often cited by papers focused on Nonmelanoma Skin Cancer Studies (7 papers), Diagnosis and Treatment of Venous Diseases (3 papers) and Cutaneous Melanoma Detection and Management (3 papers). Jens Bichel collaborates with scholars based in Germany, Netherlands and France. Jens Bichel's co-authors include Agustı́n Alomar, Eggert Stockfleth, Scott McRae, Wolfram Sterry, Rolf‐Markus Szeimies, Lanlin Ding, Thomas Ruzicka, Anita Takwale, Monique R.T.M. Thissen and Kara L. Andres and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Jens Bichel

12 papers receiving 629 citations

Peers

Countries citing papers authored by Jens Bichel

Since Specialization

Citations

This map shows the geographic impact of Jens Bichel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Bichel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Bichel more than expected).

Fields of papers citing papers by Jens Bichel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Bichel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Bichel. The network helps show where Jens Bichel may publish in the future.

Co-authorship network of co-authors of Jens Bichel

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Bichel. A scholar is included among the top collaborators of Jens Bichel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Bichel. Jens Bichel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	The Science of Skin: Measuring Damage and Assessing Risk 2022 ·Advances in Wound Care ·Stéphanie F. Bernatchez, Jens Bichel	24
2	Compression therapy of leg ulcers with PAOD 2014 ·Phlebology The Journal of Venous Disease ·Andrea Ladwig, Hermann Haase, Jens Bichel, Jan Schuren, Michael Jünger	15
3	Macro- and microperfusion during application of a new compression system, designed for patients with leg ulcer and concomitant peripheral arterial occlusive disease 2013 ·Clinical Hemorheology and Microcirculation ·Michael Jünger, Hermann Haase, (unknown), Jens Bichel, Jan Schuren, Andrea Ladwig	12
4	Sub-bandage dynamics: stiffness unravelled 2013 ·SHILAP Revista de lepidopterología ·Jan Schuren, Jens Bichel	7
5	A phase II dose-ranging study of topical resiquimod to treat actinic keratosis 2008 ·British Journal of Dermatology ·Rolf‐Markus Szeimies, Jens Bichel, J P Ortonne, Eggert Stockfleth, James Lee, (unknown)	66
6	Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head 2007 ·British Journal of Dermatology ·Eggert Stockfleth, Wolfram Sterry, (unknown), Jens Bichel	45
7	Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head 2007 ·British Journal of Dermatology ·Agustı́n Alomar, Jens Bichel, Scott McRae	91
8	Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients 2007 ·British Journal of Dermatology ·Claas Ulrich, Jens Bichel, Sylvie Euvrard, (unknown), Charlotte M. Proby, P.C.M. van de Kerkhof, Paolo Amerio, Jørgen Rønnevig, Herbert B. Slade, Eggert Stockfleth	110
9	Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology 2004 ·Journal of the American Academy of Dermatology ·Rolf‐Markus Szeimies, Marie‐Jeanne P. Gerritsen, G. Gupta, Jean Paul Ortonne, Stefano Serresi, Jens Bichel, James H. Lee, Terry L. Fox, Agustı́n Alomar	147
10	Detection and clearance of subclinical actinic keratosis (AK) with imiquimod (5%) treatment 2004 ·Journal of the American Academy of Dermatology ·Eggert Stockfleth, Jens Bichel, Claas Ulrich, Wolfram Sterry	2
11	Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion 2002 ·British Journal of Dermatology ·Wolfram Sterry, Thomas Ruzicka, (unknown), Anita Takwale, Jens Bichel, Kara L. Andres, Lanlin Ding, Monique R.T.M. Thissen	136
12	[Serious complications of sternal puncture]. 1989 ·PubMed ·Jens Bichel	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact